Thoracic Drainage Devices Market: Snapshot

The global thoracic drainage devices market is expanding at a steady pace due to increase in incidences of pneumothorax and pleural effusion, adoption of advanced technological products such as digital thoracic drainage system and increase in cardiac surgical procedures among the geriatric population. The global thoracic drainage devices market was valued over US$ US$ 555.8 Mn in 2016 and is projected to witness compound annual growth rate (CAGR) of over 6% from 2017 to 2025 to surpass the value of US$ 916.2 Mn by 2025.

Chest tube thoracostomy or a chest tube placement is a minimally invasive procedure done to drain air, fluid, or blood from the thoracic space to prevent lungs from collapsing. A chest tube is also called thoracic catheter, chest drain, or intercostal drain. The thoracic catheter is inserted in the pleural space. This procedure includes the use of different devices such as thoracic drainage system, trocar drain, unsecured needle, secured needle, pleural drainage catheter, and thoracic drainage kit. The thoracic drainage devices are majorly used for disease indications of pleural effusion, pneumothorax, traumatic pneumothorax (gunshot or stab wound) and cardiac surgery procedures. Key driving factors such as rise in patient preference for minimally invasive surgeries, high prevalence of cardiovascular diseases, increase in burden of spontaneous pneumothorax, and rise in health insurance coverage propelling adoption of thoracic drainage devices are the major factors that drives the growth of thoracic drainage devices market. Cardiovascular disease is a serious health problem affecting a large population across the globe. Hypertension, diabetes, and obesity are the leading causes of cardiovascular disorders, especially stroke, stenosis, atresia, and regurgitation. Increase in number of open heart surgeries due to unhealthy lifestyle, lack of exercise, overweight, and smoking will create significant opportunities in the thoracic drainage devices market.

thoracic-drainage-devices-market.jpg

The market for thoracic drainage devices market has been segmented broadly on the basis of different product type namely thoracic drainage system, trocar drain, unsecured needle, secured needle, pleural drainage catheter, and thoracic drainage kit. The market is further segmented into application type that includes thoracic surgery & pulmonology, cardiac surgery, general intensive care & emergency medicine, infectious disease, oncology & pain management, and military/damage control/disaster medicine. Thoracic drainage devices end-user segment includes ambulance services, hospitals & specialty clinics, urgent care or outpatient care, ambulatory surgery centers, and military surgeons. Urgent care or outpatient care and ambulance services are the rapidly growing segment owing to rise in number of spontaneous pneumothorax cases.

Spontaneous pneumothorax is a one of the major health problems across the globe. Spontaneous pneumothorax arises due to the air in the chest cavity which can resolve itself; however, most often requires a hospital admission and urgent medical care.

In terms of the application, thoracic surgery & pulmonology segment held the largest share. Thoracic and pulmonological disorders are quite common and increasing. Thoracic drainage devices are used in the treatment of pneumothorax, pleural effusions, and empyema disorders.

The health care market is likely to witness more transactions and consolidations in the next three to four years. One of the major factors driving the market is constantly rising insured population base. Expanding health insurance coverage is expected to increase demand for thoracic drainage device procedures. Patients with private coverage are more likely to seek medical treatment at an urgent care center or hospital settings. According to industry experts, favorable insurance coverage would influence the thoracic drainage devices market significantly by penetrating the sub-urban areas. These factors are expected to boost the growth of the thoracic drainage devices market

By geography, global thoracic drainage devices market has been divided into major five region: North America, Europe, Asia, Latin America and Middle East & Africa.  North America and Europe contributed the highest share of the global thoracic drainage devices market followed by Asia Pacific, Latin America, and Middle East & Africa. The U.S. dominated the thoracic drainage devices market in North America. This dominance is majorly due factors such as high cost of products and high level of end-user awareness. Also, the market in the U.S. is driven by increased adoption of newly introduced devices and insurance plans for costly cardiovascular surgical treatment. Europe is the second major contributor for the global thoracic drainage devices market. Germany is a major contributor to the thoracic drainage devices market in Europe. The thoracic drainage devices market in the Asia-Pacific is growing rapidly, driven primarily by developing countries. Growing awareness about cardiovascular diseases and expenditure on health care drive the thoracic drainage devices market in Asia Pacific. However, less penetration of healthcare facilities and lack of availability for thoracic drainage device products has become a restraining factor for thoracic drainage devices market in developing and undeveloped regions such as Latin America and Middle East & Africa.

The key players operating in the thoracic drainage devices market are Teleflex Incorporated, Vygon S.A., Medtronic plc., Cook Group Incorporated (Subsidiary: Cook Medical), C. R. Bard, Inc. (Becton, Dickinson and Company), MAQUET Holding B.V. & Co. KG (Getinge Group), Utah Medical Products, Inc., Smiths Medical, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, and Medela.

Thoracic Drainage Devices Market: Overview

This report on thoracic drainage devices market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing thoracic drainage devices products for pneumothorax and pleural effusion treatment as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thoracic drainage devices market with respect to the leading market segments based on product type, application, end-user, and geographies.

Thoracic Drainage Devices Market: Key Segments

Based on product type, the thoracic drainage devices market has been majorly segmented into: thoracic drainage system, trocar drain, unsecured needle, secured needle, pleural drainage catheter, and thoracic drainage kit. In terms of application, the thoracic drainage devices market has been broadly classified into thoracic surgery & pulmonology, cardiac surgery, general intensive care & emergency medicine, infectious disease, oncology & pain management, and military/damage control/disaster medicine. In terms of end-user, market is divided into ambulance services, hospitals & specialty clinics, urgent care or outpatient care, ambulatory surgery centers, and military surgeons. The hospitals & specialty clinics market further segmented into pulmonologist, cardiologist, infectiologist, anesthesiologist and other medical specialties.

Each of the market segments have been extensively analyzed based on the market related factors such as incidence and prevalence of pleural effusion, pneumothorax, hemothorax, spontaneous pneumothorax, tension pneumothorax, traumatic pneumothorax and cardiac tamponade, available treatment options, and thoracic drainage device products. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thoracic drainage devices market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thoracic drainage devices market.

Geographically, thoracic drainage devices market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thoracic drainage devices market.

Companies Mentioned in Report

The key players operating in the thoracic drainage devices market are Teleflex Incorporated, Vygon S.A., Medtronic plc., Cook Group Incorporated (Subsidiary: Cook Medical), C. R. Bard, Inc. (Becton, Dickinson and Company), MAQUET Holding B.V. & Co. KG (Getinge Group), Utah Medical Products, Inc., Smiths Medical, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, and Medela.

The global thoracic drainage devices market is segmented as follows:

Global Thoracic Drainage Devices Market, by Product

  • Thoracic Drainage System
  • Trocar Drain
  • Unsecured Needle
  • Secured Needle
  • Pleural Drainage Catheter
  • Thoracic Drainage Kit

Global Thoracic Drainage Devices Market, by Application

  • Thoracic Surgery & Pulmonology
  • Cardiac Surgery
  • General Intensive Care & Emergency Medicine
  • Infectious Disease
  • Oncology & Pain Management
  • Military/Damage Control/Disaster Medicine

Global Thoracic Drainage Devices Market, by End-user

  • Ambulance Services
  • Hospitals & Specialty Clinics
    • Pulmonologist
    • Cardiologist
    • Infectiologist
    • Anesthesiologist
    • Other Medical Specialties
  • Urgent Care or Outpatient Care
  • Ambulatory Surgery Centers
  • Military Surgeons

Global Thoracic Drainage Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
.